Thomas Finser
Hedge fund manager, deep value, small-cap, family office

LCA-Vision: The Case For Calculated Optimism

Laser vision correction specialist LCA-Vision (NASDAQ:LCAV) is poised for an epic rebound. After suffering through a multi-year recession, it has quietly re-emerged as more disciplined and efficient organization, with the most attractive long-term growth prospects in company history. Significant pent-up demand and a game-changing demographic inflection point remain under-appreciated by the market. Given the substantial operating leverage in LCA-Vision's fixed cost business model, disciplined investors could reap a 200% TSR in the next 36 months. Downside risk is mitigated by adroit financial management and a robust balance sheet with $1.80 per share net cash.

Reasons to Consider LCAV

The trifecta of headwinds that punished shareholders over these past five years have quietly transitioned to tail winds.

    U.S....
Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details